The rapid increase of Methicillin-resistant Staphylococcus aureus (MRSA) infections and the
cross-resistance of MRSA to other antibiotics create an urgent demand for new therapeutic …

Methicillin-resistant Staphylococcus aureus (MRSA), a biofilm-forming recalcitrant pathogen
with a multidrug-resistant profile, poses a pandemic threat to human health and is the …

Nowadays, antimicrobial peptides are promising to confront the existing global crisis of
antibiotic resistance. Here, a novel analogue peptide (mKLK) was designed based upon a D …

Staphylococcus pseudintermedius is a common commensal bacterium colonizing the skin
and mucosal surfaces of household animals. However, it has recently emerged as a …

Antibacterial and antifungal peptides have increasingly been used to combat the antibiotic‐
resistant microbes in recent years. KW‐13, a novel cationic α‐helical antibacterial peptide …

Antibiotic resistance and the shortage of novel antimicrobials are among the biggest
challenges facing society. One of the major factors contributing to resistance is the use of …

The increased resistance of microorganisms to the different antimicrobials available to today
has highlighted the need to find new therapeutic agents, including natural and/or synthetic …

Staphylococcus hyicus, considered as a leading pathogen of exudative epidermitis, is a
serious threat to humans and animals. The emergency of bacterial resistance to antibiotics …

Staphylococcus epidermidis has emerged as the main causative agent for graft-related and
nosocomial infections. Rampant use of antibiotics and biofilm formed by the organism …

Staphylococci, notably biofilm-forming Staphylococcus epidermidis, have been recognized
as global nosocomial pathogens in medical device-related infections. Their potential to …